Kazia Therapeutics (KZIA) Total Non-Current Liabilities (2017 - 2025)

Kazia Therapeutics' Total Non-Current Liabilities history spans 6 years, with the latest figure at $197893.9 for Q2 2025.

  • For Q2 2025, Total Non-Current Liabilities fell 94.83% year-over-year to $197893.9; the TTM value through Jun 2025 reached $197893.9, down 94.83%, while the annual FY2025 figure was $197893.9, 94.83% down from the prior year.
  • Total Non-Current Liabilities reached $197893.9 in Q2 2025 per KZIA's latest filing, down from $3.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $7.8 million in Q2 2022 to a low of $197893.9 in Q2 2025.
  • Average Total Non-Current Liabilities over 4 years is $4.4 million, with a median of $4.7 million recorded in 2023.
  • Peak YoY movement for Total Non-Current Liabilities: dropped 27.41% in 2023, then crashed 94.83% in 2025.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $7.8 million in 2022, then decreased by 27.41% to $5.7 million in 2023, then tumbled by 32.41% to $3.8 million in 2024, then plummeted by 94.83% to $197893.9 in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Total Non-Current Liabilities are $197893.9 (Q2 2025), $3.8 million (Q2 2024), and $5.7 million (Q2 2023).